HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -21.59 Million USD | -25.95% |
| 2021 | -17.14 Million USD | 17.85% |
| 2020 | -20.87 Million USD | -8.15% |
| 2019 | -19.29 Million USD | -17.28% |
| 2018 | -16.45 Million USD | 13.22% |
| 2017 | -18.96 Million USD | 27.19% |
| 2016 | -26.03 Million USD | -21.69% |
| 2015 | -21.39 Million USD | -53.3% |
| 2014 | -13.95 Million USD | -18.6% |
| 2013 | -11.76 Million USD | 7.86% |
| 2012 | -12.77 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | - USD | 100.0% |
| 2023 Q1 | -5.05 Million USD | -7.72% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q4 | -4.69 Million USD | -3.91% |
| 2022 Q2 | -5.88 Million USD | 9.38% |
| 2022 Q1 | -6.49 Million USD | -25.16% |
| 2022 Q3 | -4.51 Million USD | 23.3% |
| 2022 FY | -21.59 Million USD | -25.95% |
| 2021 Q2 | -2.61 Million USD | 46.06% |
| 2021 Q3 | -4.49 Million USD | -71.73% |
| 2021 FY | -17.14 Million USD | 17.85% |
| 2021 Q4 | -5.19 Million USD | -15.6% |
| 2021 Q1 | -4.84 Million USD | -13.01% |
| 2020 Q4 | -4.28 Million USD | 20.73% |
| 2020 Q3 | -5.41 Million USD | 5.23% |
| 2020 Q2 | -5.71 Million USD | -4.63% |
| 2020 Q1 | -5.45 Million USD | -24.35% |
| 2020 FY | -20.87 Million USD | -8.15% |
| 2019 FY | -19.29 Million USD | -17.28% |
| 2019 Q4 | -4.38 Million USD | 7.4% |
| 2019 Q3 | -4.74 Million USD | 1.19% |
| 2019 Q2 | -4.79 Million USD | 10.68% |
| 2019 Q1 | -5.37 Million USD | -152.41% |
| 2018 FY | -16.45 Million USD | 13.22% |
| 2018 Q4 | -2.12 Million USD | 56.07% |
| 2018 Q1 | -5.37 Million USD | -179.91% |
| 2018 Q2 | -4.1 Million USD | 23.74% |
| 2018 Q3 | -4.84 Million USD | -18.05% |
| 2017 Q4 | -1.92 Million USD | 64.28% |
| 2017 FY | -18.96 Million USD | 27.19% |
| 2017 Q1 | -5.81 Million USD | -2.52% |
| 2017 Q2 | -5.84 Million USD | -0.42% |
| 2017 Q3 | -5.38 Million USD | 7.88% |
| 2016 Q3 | -6.48 Million USD | 5.3% |
| 2016 Q2 | -6.85 Million USD | 2.49% |
| 2016 Q1 | -7.02 Million USD | -23.28% |
| 2016 FY | -26.03 Million USD | -21.69% |
| 2016 Q4 | -5.67 Million USD | 12.57% |
| 2015 FY | -21.39 Million USD | -53.3% |
| 2015 Q1 | -4.08 Million USD | 1.22% |
| 2015 Q4 | -5.69 Million USD | -10.51% |
| 2015 Q3 | -5.15 Million USD | 20.07% |
| 2015 Q2 | -6.45 Million USD | -57.83% |
| 2014 FY | -13.95 Million USD | -18.6% |
| 2014 Q3 | -3.3 Million USD | 10.24% |
| 2014 Q2 | -3.68 Million USD | -30.32% |
| 2014 Q1 | -2.82 Million USD | -7.18% |
| 2014 Q4 | -4.13 Million USD | -25.14% |
| 2013 Q4 | -2.63 Million USD | 21.58% |
| 2013 FY | -11.76 Million USD | 7.86% |
| 2013 Q2 | -3.75 Million USD | 0.0% |
| 2013 Q3 | -3.36 Million USD | 10.48% |
| 2012 FY | -12.77 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -1431.523% |
| Arrayit Corporation | -3.31 Million USD | -551.3% |
| Atlantic International Corp. | -5.62 Million USD | -283.725% |
| Biocept, Inc. | -32.08 Million USD | 32.7% |
| Bioqual, Inc. | 483.48 Thousand USD | 4566.458% |
| CardioGenics Holdings Inc | -1.91 Million USD | -1026.87% |
| DermTech, Inc. | -100.88 Million USD | 78.596% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 101.066% |
| iMD Companies, Inc. | -200.63 Thousand USD | -10663.012% |
| IDenta Corp. | 14.64 Thousand USD | 147562.961% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 2792.578% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 55915.544% |
| InVitro International | 1553.00 USD | 1390600.708% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | -151.332% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -37060.098% |
| Medical Imaging Corp. | -3.02 Million USD | -614.334% |
| NovelStem International Corp. | -4.18 Million USD | -415.714% |
| Optigenex Inc. | -2.89 Million USD | -645.213% |
| PharmChem, Inc. | 845.1 Thousand USD | 2655.251% |
| Proteome Sciences plc | -2.44 Million USD | -783.933% |
| Response Genetics, Inc | -20.18 Million USD | -6.988% |
| Rennova Health, Inc. | -3.29 Million USD | -555.758% |
| RushNet, Inc. | -607.02 Thousand USD | -3457.41% |
| ScreenPro Security Inc. | -2.24 Million USD | -860.281% |
| Stella Diagnostics Inc. | -5.7 Million USD | -278.357% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | -89.17% |
| Todos Medical Ltd. | -24.99 Million USD | 13.601% |